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[SNACC-1] Inhibition of RhoA Activity with TAT-C3 Attenuates
Propofol-mediated Neurotoxicity
Jian M*, Pearn Mw, Egawa J*, Head B*, Patel P*, Han Rz. *University
of California, San Diego, San Diego, California, United states. wUniver-
sity of California, San Diego, San Diego, California, United states.
zBeijing Tiantan Hospital, Beijing, Beijing, China.
Background: Propofol (PPF) exposure to developing neurons during syn-
aptogenesis results in neurodegeneration; the resulting cognitive dysfunction
in adulthood has bene attributed to apoptosis. However, recent data indicate
that apoptosis per se might not be the primary mechanism that leads to
cognitive dysfunction. Anesthetic induced disruption of neuronal cytoske-
leton leads to loss of neuritis, dendrites and synapses, thereby disrupting
development of neuronal networks. PPF induced activation of RhoA plays
a central role in neurite loss. Inhibition of RhoAmight prevent PPF toxicity.
To determine whether RhoA inhibition prevents neurite loss and prevents
the adverse effects of PPF on the development of neuronal networks in the
hippocampus, we investigated the effect of TAT-C3, a RhoA inhibitor, on
neurite loss in cultured rodent neurons and in mice in vivo. Similar studies
were undertaken in human neurons in vitro to determine whether RhoA is
of relevance to PPF toxicity in human tissue.
Methods: Primary fetal human neurons (Advanced Bioscience Re-
sources, Alameda, CA) and postnatal day 5-7 (PND5-7) mice were ex-
posed to PPF (3 mM) or DMSO for 6 hours, with pre-treatment of TAT
conjugated C3 (TAT-C3) (50 ug/mL, 2 h), a highly specific pharmaco-
logic inhibitor of RhoA or TAT control. RhoA activation was evaluated
by staining for RhoA-GTP (active form). Dendritic spine changes were
evaluated with the neuronal spine marker, drebrin. Changes in synapses
in PND5-7 mouse hippocampi were assessed by electron microscopy.
Histological sections of the entire hippocampus were stained for syn-
aptoporin to quantify the area and volume of suprapyramidal and in-
frapyramidal mossy fibers from the dentate granule neurons to the CA3
pyramidal neurons (SPM and IPM, respectively) in vivo.
Results: Exposure of human neurons in vitro to PPF increased active RhoA,
decreased drebrin staining, and decreased dendritic arborization. These
adverse effects of PPF were mitigated by TAT-C3. These are the first data in
human neurons to demonstrate PPF neurotoxicity. In PND7 rodent pups
exposed to PPF, a reduction in SPM was apparent. By 1 week after ex-
posure, the SPM fibers were restored. By contrast, there was a significant
reduction in IPM volume that was apparent even 4 weeks post exposure.
Conclusions:Our previous results, which demonstrated that PPF induced
toxicity was prevented by RhoA inhibition in rodent neurons, were re-
capitulated in human neurons. These data indicate that RhoA may also
play an important role in anesthetic neurotoxicity in human tissue. In
addition, our results demonstrate that PPF causes a dramatic alteration
in neuronal networks in vivo. A single exposure at PND7 led to per-
sistent alteration of the mossy fibers of hippocampus four weeks post
exposure (at PND35). This alteration in the architecture of the hippo-
campus may contribute to cognitive dysfunction in adulthood.
[SNACC-2] Effect of Early Repeated Anesthetic Exposure on
Long-term Cognition
Lee B, Sall J.University of California, San Francisco, San Francisco, CA, US.
Background: Early anesthetic exposure in humans and rodents leads to
long-term cognitive effects. In rodents, longer exposures result in worse
outcomes.1 Studies have also demonstrated that multiple anesthetic ex-
posures may be more harmful than a single exposure.2,3 Those studies,
however, do not account for the increased cumulative duration of gen-
eral anesthesia associated with multiple exposures to anesthesia.
Therefore, it is unclear whether the worse outcome is due to repeated
exposures or simply a greater total duration of anesthesia.
Methods: Postnatal day (P)7 male rats were anesthetized using iso-
flurane. In one group, subjects were exposed to isoflurane for 6 hours
continuously. In the other group, animals were anesthetized for 3 hours
on P7 and then again for 3 hours on P8, resulting in a combined total of
6 hours. A control group was included that did not undergo anesthesia.
Long-term behavioral outcome was assessed weeks later using a series of
associative memory tests which included various novel object recog-
nition (NOR) tasks and an item association task (IA). Both memory
tests evaluate context-specific memory and the ability to recognize ob-
jects and scents using specific contextual cues.
Results: Animals in the repeat exposure group (“Iso 3+3”) demon-
strated worse behavioral outcomes than those in the single exposure
group (“Iso 6”). Iso 3+3 subjects were impaired in all variants of the
NOR task while Iso 6 animals were only impaired in the most complex
task. In the IA task, both groups were impaired relative to control when
relying on proximal and distal contextual cues. Iso 3+3 (repeat ex-
posure) performed worse than Iso 6 (single exposure) in the proximal
contextual cue task.
Conclusion: Isofurane exposure in neonatal rats results in impaired long-
term associative memory. Repeated exposure leads to worse outcome
than a single exposure even when the total anesthetic duration is
equivalent.
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[SNACC-3] Caveolin-1 is a Biomarker of Propofol Mediated
Neurotoxicity in Developing Neurons
Pearn M*, Elvina D*, Patel Hw, Patel P*, P Bw. *University of California
at San Diego, San Diego, California, United States. wVeterans Affairs
Medical Center, La Jolla, California, United States.
Background: A wide body of evidence indicates that anesthetic exposure
during synaptogenesis in the developing brain causes widespread neu-
rodegeneration, electrophysiologic abnormalities of neuronal networks
and long-term cognitive deficits. Although the mechanism by which
anesthetics injure the neonatal brain is not known, GABA-A mediated
excitation, NMDAR antagonism mediated excitotoxicity, aberrant cell
cycle entry, mitochondrial injury and free radical mediated toxicity play
a role. Work from our laboratory has demonstrated that preferential
signaling of proBDNF via p75NTR leads to downstream activation ofCopyright r 2015 Wolters Kluwer Health, Inc. All rights reserved.
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[SNACC-97] Blood Transfusion and Anaemia in Patients Un-
dergoing Posterior Lumbar Interbody Fusion
Lalabekyan B*, Moss Cw, Luoma Aw. *Barts and the London School of
Medicine, London, UK. wNational Hospital for Neurology and Neuro-
surgery, London, UK.
Introduction: In-hospital blood transfusion is common, around 12% of in-
patients in the US, and is associated with increased peri-operative morbidity
and mortality in both cardiac and non-cardiac surgery. Pre-operative
anaemia is also common, present in up to 30% of patients.1,2 It is in-
dependently associated with increased 30-day morbidity & mortality after
major non-cardiac surgery including infection risk,2 which is further in-
creased by peri-operative blood transfusion.2,3 Currently decision to trans-
fuse is based on a risk benefit decision with no established recommendation
on thresholds. Posterior lumbar interbody fusion surgery [PLIF] is common
and may be associated with haemorrhage. As with any surgical implants
there is a risk of surgical site infection.
Our aim was to Establish:
[1] Mean peri-operative haemoglobin drop for PLIF.
[2] Incidence of pre-operative anaemia and peri-operative blood trans-
fusion rate.
Association with length of hospital stay [LOS].
Methods: Retrospective electronic case-note review of all patients un-
dergoing elective PLIF over a 2-year period. Data collected included:
patient demographics, length of hospital stay, peri-operative haemo-
globin drop & blood transfusion rate. Anaemia defined according to
WHO criteria.4
Results: N=157; median age 62 [30-83] years; incidence of pre-operative
anaemia 14.6%; overall transfusion rate 15.9%. Mean haemoglobin drop
31.27 [14.6] g/L. [table 1].
Anaemic patients were more likely to receive a blood transfusion [P=0.0132
Fishers Exact] but there was no significant difference in LOS between pa-
tients with pre-operative anaemia and no anaemia. Blood transfusion was
associated with significantly increased LOS [P=0.0001 unpaired t-test].
No significant difference in mean [SD] haemoglobin drop between 1-level
and more than 1-level PLIF [30.86 [14.3] g/L versus 31.98 [15.3] g/L]. No
difference in incidence of blood transfusion or LOS between the groups.
Conclusion: Pre-operative anaemia is common in patients undergoing PLIF
and associated with increased blood transfusion with subsequent increased
LOS, in keeping with published data. Mean haemoglobin drop is significant
but similar for single and multi-level PLIF, and should be considered when
preparing patients for surgery, particularly with the lack of clarity on
transfusion thresholds. Early identification and treatment of anaemia could
prevent transfusions and the resultant risk of increased morbidity and
mortality. It is essential to ensure that patients and clinicians are fully in-
formed of the risks associated with anaemia & blood transfusion to improve
patient safety, and to ensure decisions are shared.
References:
1. Toledo P. Anesth & Analg. 2014;118 (6):1151–1153.
2. Musallam et al. The Lancet. 2011;378 (9800):1396–1407.
3. Saager et al. Anesth & Analg. 2013;117 (4):909–915.
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[SNACC-98] A Survey on the Practice of Anesthesia Induction
and Loss of Consciousness Assessment
Ferreira A*, Nunes Cw, Gabriel J*, Lobo Fz, Amorim Pz. *Faculdade
De Engenharia Da Universidade Do Porto, Porto, Portugal. wUniversi-
dade Aberta and Centro De Investigalcao Em Anestesiologia Chp, Porto,
Portugal. zCentro Hospital Do Porto, Porto, Portugal.
Propofol is the mostly used drug for induction in all cases or maintenance in
total intravenous anesthesia. For induction it is given as a manual bolus
based on the patient’s weight. TCI systems are now increasingly used, al-
lowing information regarding predicted plasma and brain concentrations
and the administration of propofol by setting a concentration target. In-
duction and maintenance with propofol, should be performed avoiding
excessive anesthesia. Knowledge of pharmacokinetics (effect of bolus ve-
locity, magnitude of overshooting and relation to velocity) and pharmaco-
dynamics (fall in blood pressure, usage and correct interpretation of BIS) is
important for better titration of anesthesia. We conducted a survey to assess
how Portuguese anesthesiologists use propofol to induce and maintain
general anesthesia, how they use TCI, interpret BIS, identify overshooting
and assess loss of consciousness (LOC).
Figure 1: A - Response distribution regarding the chosen dosage for propofol and the
chosen infusion velocity to achieve loss of consciourness.




Anesthesiologists working at 10 large public hospitals in Portugal were sent
an email requesting them to answer an on-line survey. IRB approval was
obtained. Preceding the questions, a clinical scenario was presented: a male
patient (50y, 60kg, 160 cm, ASA I), unpremedicated is ready to undergo
general anesthesia and tracheal intubation for a laparotomy procedure to
perform a cholecystectomy. 0.15mg of fentanyl were administered 3 minutes
before induction with 1% propofol using a 20 cc syringe. The anesthesiol-
ogist is at the bedside, pre-oxygenating, monitoring and instructing a nurse
administering the drugs through an IV line inserted in the back of the
patient’s hand. Standard monitoring is ASA and BIS. A total of 118
anonymous responses were received and some of the results are summarized.
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In the scenario above, 44% of anesthesiologists chose 120mg as the
dosage of propofol they would administer to induce LOC and 32%
chose 1200mL/h as the infusion velocity (there was no significant cor-
relation between variables) (Fig. 1). The majority (56%) assess LOC by
the loss of eyelid reflex, 18% rely on the BIS and 16% on the absence of
movement. A BIS below 60 was chosen by 38% as the value at which
patients, on average lose consciousness (Fig. 1). When asked about the
use of TCI of propofol (PK Schnider), 22% perform induction by setting
a fixed brain target, 4% by stepwise increasing the brain target, 9% by a
fixed plasma target, 3% by stepwise increasing the plasma target, 24.6%
use the TCI-View mode and 36.4% never used TCI. When asked to
choose a figure for the magnitude of the effect site overshooting of
propofol if given with the infusion velocity chosen for the induction, a
significant positive Spearman correlation between the chosen infusion
velocity and the chosen overshooting was found (R=0.249, P<0.01).
This survey showed a wide variation in the way propofol is used and in
the interpretation and knowledge of pharmacology.
Funding: FCT: UID/SEM/50022/2013 and SFRH/BD/98915/2013.
[SNACC-99] Factors Affecting the Outcome of Patients Under-
going Surgery for Craniopharyngioma
Mitra R, Prabhakar H, Rath G, Bithal P. All India Institute of Medical
Sciences, New Delhi, Delhi, India.
Introduction: The incidence of craniopharyngioma is stated around 1.3
per million person-years; the incidence is higher in India with 10.2%.
This study was conducted to determine the perioperative factors that
affect the outcome of patients undergoing surgery for craniophar-
yngioma. The primary outcome was duration of hospital and intensive
care unit (ICU) stay and Glasgow outcome scale (GOS) at discharge.
The secondary outcome was the quality of life (QOL) at 3 month and 6
month after discharge from hospital.
Methods: All patients aged 5 year and above of either sex, scheduled for
elective craniopharyngioma surgeries from 1st April 2014 to 31st March
2015 were included in the study. The demographics, baseline characteristics
(admission Glasgow coma scale, tumor size, hormonal status, location,
hydrocephalus, hypothalamic involvement), intraoperative data (anesthesia
and surgery related), GOS at discharge, and postoperative QOL assessed
using the Health Utility indices (HUI-2/3) for a period up to 6 months after
surgery were collected. Appropriate statistical analysis was done. Data are
presented as median [Range], mean (SD) or number (%).
Results: Twenty two patients were included in the study. The duration of
hospital and ICU stay were 17 days (6-64) and 3.5 days (1-25), re-
spectively. The GOS at discharge was 5 (2-5). There was no in-hospital
mortality. The baseline prolactin level and involvement of hypothalamus
affects GOS at discharge. The quality of life at 3rd and 6th month did
not change significantly when compared to baseline (i.e. health status of
patient 1wk prior to admission to hospital). No factor affecting the QOL
could be identified.
Conclusion: None of the demographic or perioperative factors affecting
the QOL of patients with craniopharyngioma could be identified. Larger
series may be studied for definitive outcomes.
[SNACC-100] Awake Craniotomy with Intraoperative MRI
(iMRI): Our Anaesthetic Experience in a 1.5T iMRI Integrated
Surgical Suite
John R*, Appleby Iw. *National Hospital for Neurology and Neuro-
surgery, London, United Kingdom. wNational Hospital for Neurology an
Neurosurgery, London, United Kingdom.
Background: To help maximize the resection of lesions located in elo-
quent cortex and preserve function, patients can undergo awake cra-
niotomy with cortical mapping, or intraoperative MRI surgery.1–3 There
has been little experience combining these two techniques in the United
Kingdom.
Objectives: We report our anaesthetic experience of combining awake
craniotomy with intraoperative brain mapping within an integrated 1.5
T intraoperative magnetic resonance imaging (iMRI) suite.
Methods: From a prospective database we identified all patients who had
undergone awake craniotomy procedures with cortical mapping in the
integrated iMRI suite. We evaluated how these two modalities were
integrated, and what impact this combined technique had on safety,
workflow, extent of surgical resection and total operative time.
Results: Between February 2015 and April 2015, five patients (3 male and 2
female patients; age 30-48; mean 41y) with lesions in, or adjacent to, elo-
quent cortex underwent awake craniotomies with iMRI surgery. Two pa-
tients had right sided lesions and three had left sided lesions. The “asleep-
awake-asleep” technique with a laryngeal mask airway was used in all pa-
tients. Scalp blocks were administered by the surgeon performing the cra-
niotomy. Anaesthesia was maintained using either sevoflurane with a
remifentanil infusion (3/5) or twin propofol/remifentanil infusions (2/5). All
patients had two intraoperative scans, with the mean time per scan being
29 minutes (range, 20-40min). During the intraoperative scanning phase, the
anaesthetic consultant was always present in the MRI suite. The mean
surgical time was 7.6 hours (range, 6.5-10h) and the extent of surgical
resection was>95% in all five cases. One patient had an intraoperative
seizure, but no other complications were noted in our case series.
Conclusions: Awake craniotomy and direct cortical stimulation can be per-
formed safely and effectively within a 1.5T iMRI suite. Our preliminary case
series is the first from the United Kingdom, and shows that both volatile and
intravenous anaesthesia are well tolerated in this setting. This emerging
technique however prolongs the total surgical time significantly. Careful
patient selection and preparation is therefore crucial.
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[SNACC-101] The Effect of Remifentanil Infusion on Successful
Cortical Mapping During Awake Craniotomies
Hammer M*, Kosky J*, Hemmer L*, Bebawy J*, Tate M*, Gupta Dw,
Koht A*. *Northwestern Memorial Hospital, Chicago, IL, United States.
wDuke University, Durham, NC, United States.
Introduction: Awake craniotomy is an increasingly common surgical
modality used to resect masses in and around the eloquent and motor
areas, and ensuring patient comfort and cooperation during the proce-
dure is paramount. Many studies have been published that suggest
successful anesthetic techniques for optimizing conditions during corti-
cal mapping. However, these studies generally discontinued sedation
during the mapping period, out of concern that these medications in-
terfere with the accuracy of mapping the eloquent cortex. In this ob-
servational crossover study, we assessed the ability to perform cortical
mapping via cortical stimulation during remifentanil infusion.
Methods: All patients received scalp blocks with sedation upon arrival to
the operating room. A sedation regimen of remifentanil 0.03-0.18mcg/
kg/min and propofol 5-25mcg/kg/min was subsequently started, titrat-
ing dosages to maintain a respiratory rate of 8-12/minute. When the time
for cortical mapping approached, infusions were discontinued for at
least 15 minutes prior to allow washout. After completion of stimulation
for cortical mapping, remifentanil was restarted for five minutes at
0.1mcg/kg/min (if the maintenance infusion used before was at 0.1mcg/
km/min or higher). If the maintenance infusion of remifentanil was less
than 0.1mcg/kg/min, the starting infusion during this study period was
adjusted down to that level. After five minutes of the infusion, the dose
was decreased to half the initial study infusion for five more minutes to
achieve a patient-specific steady state concentration. The neurosurgeon
then repeated sensory, motor and speech mapping to the previously
labeled cortical areas. We examined the ability to gain the same re-
sponses during this time (i.e., remifentanil infusion study period).
Results: Thirteen subjects successfully completed the study, with a total
of 119 stimulations that were repeated after the remifentanil infusion
was restarted. Three patients were dropped from the study due to in-
traoperative complications (seizure or dysphagia). Sensory mapping was
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